Home
Journal Information
About
Aims and Scope
Contacts and Editorial Office
Editorial Board
Editor in Chief
Publisher-npj
Publication Ethics and Malpractice Statement-npj
DISCLAIMER
Editorial Policies of society of diabetic nephropathy prevention
Conflicts of Interest
Guidelines
For Reviewers
Peer Review Process
Human and Animal Rights
Author's agreement form
Checklist for Review
Editorial Workflow
Informed Consent
Open Access
Contact Us
Create Account
Login
Title
Abstract
Key words
First name (Authors)
Last name (Authors)
Search
eISSN
:
2345-4202
NPJ, 2019, v.8(1)
×
Journal of Nephropharmacology
Publisher
Society of Diabetic Nephropathy Prevention
Hypothesis
1.
Cisplatin therapy and the problem of gender-related nephrotoxicity
Hamid Nasri
*
J Nephropharmacol
. 2013;2(2):13-14.
Abstract
PDF
XML
×
Cisplatin therapy and the problem of gender-related nephrotoxicity
Short Communication
2.
Biopsy series of acute kidney injury from a tertiary care referral center in south India
Siddappa Sujatha
*,
Kowalya Ramprasad
J Nephropharmacol
. 2015;4(1):43-45.
Abstract
PDF
XML
×
Biopsy series of acute kidney injury from a tertiary care referral center in south India
Mini-Review
3.
Prevention of cisplatin nephrotoxicity
Fatemeh Hayati
,
Mehran Hossainzadeh
,
Shokouh Shayanpour
,
Zahra Abedi-Gheshlaghi
,
Seyed Seifollah Beladi Mousavi
*
J Nephropharmacol
. 2016;5(1):57-60.
Abstract
PDF
XML
×
Prevention of cisplatin nephrotoxicity
Epidemiology and Prevention
4.
Acute kidney injury due to ciprofloxacin for treatment of acute pyelonephritis
Beuy Joob
*,
iroj Wiwanitkit
J Nephropharmacol
. 2016;5(2):73-74.
PMCID:
PMC5297569
PMID:
28197506
Abstract
PDF
XML
×
Acute kidney injury due to ciprofloxacin for treatment of acute pyelonephritis
Original
5.
Clinical profile of kidney involvement preceding diagnosis of multiple myeloma; a single center experience
Manish R Balwani
*,
Manoj R. Gumber
,
Pankaj R. Shah
,
Vivek B. Kute
,
Himanshu V. Patel
,
Divyesh P. Engineer
,
Dinesh N Gera
,
Umesh Godhani
,
Rajesh Singh Gautam
,
Hargovind L. Trivedi
J Nephropharmacol
. 2016;5(2):98-101.
PMCID:
PMC5297574
PMID:
28197511
Abstract
PDF
XML
×
Clinical profile of kidney involvement preceding diagnosis of multiple myeloma; a single center experience
Case Report
6.
Manifestation of paroxysmal nocturnal hemoglobinuria as repeated acute kidney injury
Manish R Balwani
*,
Vivek B Kute
,
Pankaj R Shah
,
Maulin Shah
,
Umesh Varyani
,
Hargovind L. Trivedi
J Nephropharmacol
. 2016;5(2):116-118.
PMCID:
PMC5297565
PMID:
28197517
Abstract
PDF
XML
×
Manifestation of paroxysmal nocturnal hemoglobinuria as repeated acute kidney injury
Review
7.
Proton-pump inhibitors and risk of renal disease
Mahrang Hedaiaty
,
Mohammad Reza Tamadon
,
Armin Amiri
,
Leila Mahmoodnia
*
J Nephropharmacol
. 2017;6(2):33-37.
Abstract
PDF
XML
×
Proton-pump inhibitors and risk of renal disease
Case Series
8.
Hospital-acquired nephrotoxic exposures in the precipitation of acute kidney injury – A case series analysis and a call for more preventative nephrology practices
Macaulay Amechi Onuigbo
*,
Eileen Samuel
,
Nneoma Agbasi
J Nephropharmacol
. 2017;6(2):90-97.
Abstract
PDF
XML
×
Hospital-acquired nephrotoxic exposures in the precipitation of acute kidney injury – A case series analysis and a call for more preventative nephrology practices
Case Report
9.
Proposed laboratory surrogate markers for the management of acute kidney injury in ethylene glycol poisoning in resource-challenged countries; a Mayo Clinic Health System, Wisconsin, case analysis
Macaulay Amechi Onuigbo
,
Eileen Samuel
,
Nneoma Agbasi
,
Adel Zurob
J Nephropharmacol
. 2018;7(1):46-49.
Abstract
PDF
XML
×
Proposed laboratory surrogate markers for the management of acute kidney injury in ethylene glycol poisoning in resource-challenged countries; a Mayo Clinic Health System, Wisconsin, case analysis
Mini-Review
10.
Administration of metformin in clinical medicine; an updated mini-review on current findings
Mahrang Hedaiaty
*
J Nephropharmacol
. 2018;7(2):61-65.
Abstract
PDF
XML
×
Administration of metformin in clinical medicine; an updated mini-review on current findings
Case Report
11.
The demise of contrast nephropathy; can this be true? A contrarian view; a representative case report of contrast nephropathy from Mayo Clinic Health System in Northwestern Wisconsin
Macaulay Amechi Onuigbo
*,
Eileen Samuel
,
Nneoma Agbasi
J Nephropharmacol
. 2018;7(2):68-73.
Abstract
PDF
XML
×
The demise of contrast nephropathy; can this be true? A contrarian view; a representative case report of contrast nephropathy from Mayo Clinic Health System in Northwestern Wisconsin
Case Report
12.
Rituximab in ANCA-associated vasculitis presenting with severe acute kidney injury; a case report
Macaulay Onuigbo
*,
Julius Seok
,
Ikenna Anyamene
,
Fortunate Ejimone
,
Chinenye Eze-Raphael
,
In-Ah Vanessa Park
J Nephropharmacol
. 2019;8(1):13-13. doi:
10.15171/npj.2019.13
Abstract
PDF
XML
×
Rituximab in ANCA-associated vasculitis presenting with severe acute kidney injury; a case report
Submit Your Paper
Instructions for Authors
Aims and Scope
Editorial Board
Publication Ethics
Editorial Policy
Archive
Indexing Information
Journal of Nephropharmacology follows:
×
Powered by
© Copyright 2010-2017 MAAD-Rayan ICT Inc. All rights reserved.
Paper Press (Ppress) v.1.0.1
Designed by:
MAAD-Rayan ICT.
All rights reserved.
Email:
khosravi.r@gmail.com
MAAD-Rayan ICT Inc.